BIIL-260 hydrochloride
BIIL-260 hydrochloride is a potent, orally bioavailable antagonist of the leukotriene B4 (LTB4) receptor. It competitively and reversibly inhibits LTB4-mediated signaling, such as calcium mobilization in human neutrophils. This makes it a valuable research tool for studying LTB4's role in inflammatory diseases like psoriasis, arthritis, and COPD in both cellular and animal models.
Product Specifications
CAS Number
192581-24-1
Product Name Alternative
BIIL260 hydrochloride, BIIL-260 Hydrochloride, MOP, NOP, LTB4 receptor1110
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.89% (May vary between batches)
Solubility
DMSO:100 mg/mL (198.8 mM)
Smiles
Cl.N=C (N) C1=CC=C (OCC2=CC=CC (=C2) COC3=CC=C (C=C3) C (C4=CC=C (O) C=C4) (C) C) C=C1
Molecular Formula
C30H31ClN2O3
Molecular Weight
503.03
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
DKC1 Recombinant Antibody, PE-Cy5 Conjugated
DKC1 Recombinant Antibody, PE-Cy5 Conjugated
RMD2, ID (FAM82A1, FAM82A, Regulator of microtubule dynamics protein 2, Protein FAM82A1) (Biotin) discontinued
Lentiviral human ZBTB20 shRNA (UAS) - Lentiviral human ZBTB20 shRNA (UAS) (100)